1. Home
  2. CTRN vs CABA Comparison

CTRN vs CABA Comparison

Compare CTRN & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citi Trends Inc.

CTRN

Citi Trends Inc.

HOLD

Current Price

$57.45

Market Cap

460.5M

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.99

Market Cap

495.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRN
CABA
Founded
1946
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
460.5M
495.7M
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
CTRN
CABA
Price
$57.45
$2.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$52.00
$14.50
AVG Volume (30 Days)
247.6K
6.5M
Earning Date
06-02-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
112.14
10.26
EPS
0.91
N/A
Revenue
$819,962,000.00
N/A
Revenue This Year
$8.81
N/A
Revenue Next Year
$8.35
N/A
P/E Ratio
$63.40
N/A
Revenue Growth
8.88
N/A
52 Week Low
$28.45
$1.26
52 Week High
$66.38
$4.23

Technical Indicators

Market Signals
Indicator
CTRN
CABA
Relative Strength Index (RSI) 57.18 43.49
Support Level $42.10 $2.77
Resistance Level $66.38 $3.42
Average True Range (ATR) 3.44 0.24
MACD -0.48 0.02
Stochastic Oscillator 32.50 31.94

Price Performance

Historical Comparison
CTRN
CABA

About CTRN Citi Trends Inc.

Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

Share on Social Networks: